Last update Nov. 8, 2024

Vilanterol Trifenatate

Compatible

Safe product and/or breastfeeding is the best option.

Bronchodilator with similar characteristics to salbutamol and terbutaline, but with prolonged action like salmeterol. Use in combination with fluticasone and/or umeclidinium in the treatment of asthma. Inhaled administration.

As of the last update, we found no published data on its excretion in breast milk.

Its pharmacokinetic data (large volume of distribution, moderately high molecular weight and high percentage of protein binding) make it very unlikely to pass into breast milk in clinically significant quantities.

Its low oral bioavailability makes it difficult to pass into infant plasma from ingested breast milk, except in premature infants and the immediate neonatal period in which there may be greater intestinal permeability.

Terbutaline, a molecule of the same family, is excreted in negligible amounts in breast milk.

Several medical societies and expert authors consider safe the use of inhaled bronchodilators during lactation due to the low maternal serum levels reached. (Lactmed, Bendien 2024, National Asthma 2004, Nelson 2001, Ellsworth 1994)

Alternatives

We do not have alternatives for Vilanterol Trifenatate since it is relatively safe.

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

Vilanterol Trifenatate in other languages or writings:

Group

Vilanterol Trifenatate belongs to this group or family:

Tradenames

Main tradenames from several countries containing Vilanterol Trifenatate in its composition:

  • Anoro™. Contains other elements than Vilanterol Trifenatate in its composition
  • Anoro (Аноро)™. Contains other elements than Vilanterol Trifenatate in its composition
  • Breo™. Contains other elements than Vilanterol Trifenatate in its composition
  • Breo Ellipta™. Contains other elements than Vilanterol Trifenatate in its composition
  • Elebrato™. Contains other elements than Vilanterol Trifenatate in its composition
  • Laventair™. Contains other elements than Vilanterol Trifenatate in its composition
  • Relvar™. Contains other elements than Vilanterol Trifenatate in its composition
  • Relvar Ellipta™. Contains other elements than Vilanterol Trifenatate in its composition
  • Relvare™. Contains other elements than Vilanterol Trifenatate in its composition
  • Revinty™. Contains other elements than Vilanterol Trifenatate in its composition
  • Temybric™. Contains other elements than Vilanterol Trifenatate in its composition
  • Trelegy™. Contains other elements than Vilanterol Trifenatate in its composition

Pharmacokinetics

Variable Value Unit
Oral Bioavail. < 2 (Inhal: 27) %
Molecular weight 775 daltons
Protein Binding 94 %
VD 2.35 l/Kg
pKa 10.2 -
Tmax 0.2 hours
11 - 21 hours

References

  1. Bendien SA, de Kruif MD, Feitsma H, van Hoolwerff-Blikkendaal C, Huurne KK, Kuiterman A, Baranova EV, Wittkamp A, Brons A, Poulissen M, van der Meer AN. Summary of the Dutch Multidisciplinary Practice Guideline on Asthma and Pregnancy. J Allergy Clin Immunol Pract. 2024 Jul;12(7):1751-1762. Consulted on Nov. 7, 2024 Abstract
  2. LactMed. Drugs and Lactation Database (LactMed). Internet. Bethesda (MD): National Library of Medicine (US); 2006-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK501922/ 2006 - Consulted on April 16, 2024 Full text (link to original source)
  3. Middleton PG, Gade EJ, Aguilera C, MacKillop L, Button BM, Coleman C, Johnson B, Albrechtsen C, Edenborough F, Rigau D, Gibson PG, Backer V. ERS/TSANZ Task Force Statement on the management of reproduction and pregnancy in women with airways diseases. Eur Respir J. 2020 Feb 6;55(2). pii: 1901208. Abstract Full text (link to original source) Full text (in our servers)
  4. Kelleher DL, Mehta RS, Jean-Francois BM, Preece AF, Blowers J, Crater GD, Thomas P. Safety, tolerability, pharmacodynamics and pharmacokinetics of umeclidinium and vilanterol alone and in combination: a randomized crossover trial. PLoS One. 2012 Abstract
  5. Nelson-Piercy C. Asthma in pregnancy. Thorax. 2001 Abstract Full text (link to original source) Full text (in our servers)
  6. Ellsworth A. Pharmacotherapy of asthma while breastfeeding. J Hum Lact. 1994 Abstract

Total visits

8,887

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 of United States of America

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM